Literature DB >> 26094174

Housekeeping genes for studies of plasma microRNA: A need for more precise standardization.

Jonathan Rice1, Henry Roberts1, Shesh N Rai2, Susan Galandiuk3.   

Abstract

INTRODUCTION: Plasma microRNAs (miRNAs) are promising biomarkers for many forms of cancer in humans; however, a fundamental concern is the lack of standardization in current data acquisition and reporting. Part of this problem lies in the use of numerous, different housekeeping genes (HKG) for the acquisition of real-time polymerase chain reaction data. This existing practice of using different HKGs generally is accepted, but reproducibility of data for comparison and validation between different laboratories calls for improvement. The need for data reproducibility standardization is crucial. An ideal plasma HKG (1) should be expressed in all samples, (2) have medium-to-high levels of expression, and (3) have consistently measurable levels of expression.
METHODS: Total RNA was extracted from 200-μL plasma samples via a modified miRNeasy (QIAGEN) extraction technique with yeast carrier. Total RNA purity was assessed with a Nanodrop 2000 spectrophotometer (Thermo Scientific). The cycle threshold (Ct) was fixed at 0.03 for all samples. We investigated 10 potential HKGs based both on reports in the literature and our previous data. The potential HKGs were Let-7a, Let-7d, Let-7g, miR-16, RNU6, RNU48, miR-191, miR-223, miR-484, and miR-520d-5p. Once all samples were run for each potential HKG, the mean Ct and SD was calculated for all sample groups, allowing for comparison among HKGs.
RESULTS: We screened 380 miRNAs by using microfluidic array technology (Applied Biosystems) in a discovery cohort of 20 colorectal cancer (CRC) patients, 10 patients each with breast cancer (BC), lung cancer (LC), pancreatic cancer (PC), 11 patients with colorectal adenoma, and 12 controls. The mean Ct and SD was calculated for RNU6, miR-520d-5p, miR-16, miR-191, miR-223, and miR-484, which were expressed in all samples. Let-7a, Let-7d, Let-7g, and RNU48 were only expressed in 26%, 7%, 10%, and 8% of samples, respectively, and therefore were deemed to be insufficiently reliable HKGs. Only miRNAs with >50% expression were included in this statistical analysis. U6 and miR-520d-5p had the most consistent Ct as well as the least SD. The use of both RNU6 and 520d-5p as HKGs provided reliable results.
CONCLUSION: Among HKGs that were expressed in all samples, we suggest that RNU6 and miR-520d-5p were the best candidates for HKGs for studies of plasma miRNA because of the consistent and high Ct in all samples and a very narrow, reproducible SD.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26094174     DOI: 10.1016/j.surg.2015.04.025

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  28 in total

1.  Identification of suitable reference microRNA for qPCR analysis in pediatric inflammatory bowel disease.

Authors:  Christie Buonpane; Guillermo Ares; Beshoy Benyamen; Carrie Yuan; Catherine J Hunter
Journal:  Physiol Genomics       Date:  2019-04-12       Impact factor: 3.107

2.  A Highly Predictive Model for Diagnosis of Colorectal Neoplasms Using Plasma MicroRNA: Improving Specificity and Sensitivity.

Authors:  Jane V Carter; Henry L Roberts; Jianmin Pan; Jonathan D Rice; James F Burton; Norman J Galbraith; Maurice R Eichenberger; Jeffery Jorden; Peter Deveaux; Russell Farmer; Anna Williford; Ziad Kanaan; Shesh N Rai; Susan Galandiuk
Journal:  Ann Surg       Date:  2016-10       Impact factor: 12.969

3.  Relationship of Circulating miRNAs with Insulin Sensitivity and Associated Metabolic Risk Factors in Humans.

Authors:  Elizabeth Ma; Yuchang Fu; W Timothy Garvey
Journal:  Metab Syndr Relat Disord       Date:  2018-01-23       Impact factor: 1.894

4.  Identification of reference genes and miRNAs for qRT-PCR in human esophageal squamous cell carcinoma.

Authors:  Li Chen; Yulin Jin; Lin Wang; Fenghao Sun; Xiaodong Yang; Mengkun Shi; Cheng Zhan; Yu Shi; Qun Wang
Journal:  Med Oncol       Date:  2016-11-26       Impact factor: 3.064

5.  miRNA Expression in Ovarian Cancer in Fresh Frozen, Formalin-fixed Paraffin-embedded and Plasma Samples.

Authors:  Patrick H D Petersen; Joanna Lopacinska-Jørgensen; Douglas V N P Oliveira; Claus K Høgdall; Estrid V Høgdall
Journal:  In Vivo       Date:  2022 Jul-Aug       Impact factor: 2.406

6.  Antiphospholipid antibody-induced miR-146a-3p drives trophoblast interleukin-8 secretion through activation of Toll-like receptor 8.

Authors:  Stefan M Gysler; Melissa J Mulla; Marta Guerra; Jan J Brosens; Jane E Salmon; Lawrence W Chamley; Vikki M Abrahams
Journal:  Mol Hum Reprod       Date:  2016-03-29       Impact factor: 4.025

Review 7.  Considering Exosomal miR-21 as a Biomarker for Cancer.

Authors:  Jian Shi
Journal:  J Clin Med       Date:  2016-03-29       Impact factor: 4.241

8.  Reference miRNAs for colorectal cancer: analysis and verification of current data.

Authors:  E Danese; A M Minicozzi; M Benati; E Paviati; G Lima-Oliveira; M Gusella; F Pasini; G L Salvagno; M Montagnana; G Lippi
Journal:  Sci Rep       Date:  2017-08-21       Impact factor: 4.379

9.  MicroRNA Expression in Malignant Pleural Mesothelioma and Asbestosis: A Pilot Study.

Authors:  Paola Mozzoni; Luca Ampollini; Matteo Goldoni; Rossella Alinovi; Marcello Tiseo; Letizia Gnetti; Paolo Carbognani; Michele Rusca; Antonio Mutti; Antonio Percesepe; Massimo Corradi
Journal:  Dis Markers       Date:  2017-07-03       Impact factor: 3.434

10.  Natalizumab Therapy Modulates miR-155, miR-26a and Proinflammatory Cytokine Expression in MS Patients.

Authors:  Giuseppe Mameli; Giannina Arru; Elisa Caggiu; Magdalena Niegowska; Stefania Leoni; Giordano Madeddu; Sergio Babudieri; Gian Pietro Sechi; Leonardo A Sechi
Journal:  PLoS One       Date:  2016-06-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.